Myasthenia Gravis: New Modes of Action and New Targets Are Becoming Available
The treatment of myasthenia gravis has followed an escalation principle, however the dilemma is that severe symptoms usually occur within the first two years of diagnosis. In this MEDtalk, Sini Laakso takes you through the current and coming treatment options, where new modes of action and new targets are becoming available for patients.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in